Sale!

PXDN Gene Corneal opacification and other ocular anomalies Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PXDN gene plays a crucial role in ocular development and function. Mutations in this gene have been linked to corneal opacification and various other ocular anomalies, which can impact vision quality and lead to significant visual impairment. To identify mutations in the PXDN gene that may contribute to these conditions, DNA Labs UAE offers a specialized genetic test.

This genetic test involves analyzing the patient’s DNA to detect any abnormalities or mutations in the PXDN gene that could be responsible for the development of corneal opacification and other related ocular anomalies. Early detection through this test can be crucial for the management and treatment of these conditions, offering a chance to mitigate the progression of symptoms and improve the patient’s quality of life.

The test is priced at 4400 AED and is conducted in DNA Labs UAE’s state-of-the-art facilities. The lab employs cutting-edge technology and adheres to the highest standards of accuracy and reliability in genetic testing. Upon completion, a comprehensive report is provided, detailing the findings and, if applicable, recommendations for follow-up care or interventions. This test is an invaluable tool for individuals at risk of PXDN gene-related ocular conditions, enabling proactive healthcare decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test

At DNA Labs UAE, we offer the PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test for individuals who are experiencing symptoms related to corneal opacification and other ocular anomalies. This test can provide valuable information for diagnosis, prognosis, and treatment planning.

Test Details

The PXDN gene is associated with corneal opacification and other ocular anomalies. Through next-generation sequencing (NGS) technology, we can analyze the DNA sequence of the PXDN gene to identify any mutations or variations that may be contributing to the development of these conditions.

Corneal opacification is a condition where the cornea becomes cloudy, leading to impaired vision or blindness. Other ocular anomalies associated with the PXDN gene include cataracts, microphthalmia (small eye size), and aniridia (absence of the iris).

By undergoing this genetic test, individuals can gain valuable insights into their ocular conditions. This information can help with diagnosis, prognosis, and treatment planning. Additionally, it can also provide important insights into the underlying genetic causes of these conditions, which can aid researchers in developing new treatments and therapies in the future.

Test Components and Price

The PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card for analysis.

Report Delivery and Method

Once the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology for accurate and comprehensive analysis.

Doctor and Test Department

This test is conducted under the supervision of an ophthalmologist. Our dedicated genetics department handles the analysis and interpretation of the test results.

Pre-Test Information

Prior to undergoing the PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PXDN Gene Corneal Opacification and Other Ocular Anomalies NGS Genetic DNA Test gene PXDN.

This pre-test information helps in understanding the patient’s background and identifying any potential risk factors.

Conclusion

The PXDN Gene Corneal Opacification and Other Ocular Anomalies Genetic Test offered by DNA Labs UAE is a valuable tool for individuals experiencing symptoms related to corneal opacification and other ocular anomalies. The test provides crucial information for diagnosis, prognosis, and treatment planning, as well as aiding researchers in developing new treatments and therapies in the future.

Test Name PXDN Gene Corneal opacification and other ocular anomalies Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PXDN Gene Corneal opacification and other ocular anomalies NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PXDN Gene Corneal opacification and other ocular anomalies NGS Genetic DNA Test gene PXDN
Test Details

The PXDN gene is associated with corneal opacification and other ocular anomalies. Next-generation sequencing (NGS) genetic testing can be used to analyze the DNA sequence of the PXDN gene to identify any mutations or variations that may be contributing to the development of these ocular conditions.

Corneal opacification is a condition where the cornea becomes cloudy, which can lead to impaired vision or blindness. Other ocular anomalies associated with the PXDN gene include cataracts, microphthalmia (small eye size), and aniridia (absence of the iris).

NGS genetic testing can provide valuable information for individuals with these ocular conditions, as well as their family members who may be at risk for developing them. This information can help with diagnosis, prognosis, and treatment planning.

In addition, NGS genetic testing can also provide important insights into the underlying genetic causes of these conditions, which can help researchers develop new treatments and therapies in the future.